Dr Andrew B Nixon
Current affiliation: Duke University
Subject: Medicine And Medical Sciences
Primary location: United States
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
Published in:Cancer Medicine
Publication date:2014-02-14
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin,...
Published in:Cancer Medicine
Publication date:2013-03-06
A facile synthesis of 1-O-alkyl-2-(R)-hydroxypropane-3-phosphonocholine (lyso-phosphono-platelet activating factor)
Published in:Chemistry and Physics of Lipids
Publication date:1992-10-01
Activation of 85 kDa PLA2 by Eicosanoids in Human Neutrophils and Eosinophils
Published in:Advances in Experimental Medicine and Biology
Publication date:1996-01-01
Evaluation of phospholipase C and D activity in stimulated human neutrophils using a phosphono analog of choline phosphoglyceride
Published in:Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Publication date:1993-07-01
5-Lipoxygenase Products Modulate the Activity of the 85-kDa Phospholipase A2 in Human Neutrophils
Published in:Journal of Biological Chemistry
Publication date:1995-11-03
Differential activation of human neutrophil cytosolic phospholipase A2 and secretory phospholipase A2 during priming by 1,2-diacyl- and 1-O-alkyl-2...
Published in:Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Publication date:1998-11-01
Comparison of alkylacylglycerol vs. diacylglycerol as activators of mitogen-activated protein kinase and cytosolic phospholipase A2 in human neutro...
Published in:Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Publication date:1997-08-01
Comparison of acceptor and donor substrates in the CoA-independent transacylate reaction in human neutrophils
Published in:Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Publication date:1996-05-01
5-Oxo-eicosanoids and Hematopoietic Cytokines Cooperate in Stimulating Neutrophil Function and the Mitogen-activated Protein Kinase Pathway
Published in:Journal of Biological Chemistry
Publication date:1996-07-26
The Targeting of Leukocytes by 5-Oxo-Eicosanoids
Published in:Frontiers in Bioactive Lipids
Publication date:1996-01-01
Acetyl-CoA:1-O-Alkyl-2-lyso-sn-glycero-3-phosphocholine Acetyltransferase Is Directly Activated by p38 Kinase
Published in:Journal of Biological Chemistry
Publication date:1999-02-26
Phosphorylation and Nuclear Translocation of a Regulator of G Protein Signaling (RGS10)
Published in:Journal of Biological Chemistry
Publication date:2001-07-06
The Interaction of RGSZ1 with SCG10 Attenuates the Ability of SCG10 to Promote Microtubule Disassembly
Published in:Journal of Biological Chemistry
Publication date:2002-03-06
Analysis of the Regulation of Microtubule Dynamics by Interaction of RGSZ1 (RGS20) with the Neuronal Stathmin, SCG10
Published in:Methods in Enzymology
Publication date:2004-01-01
A Role for Gz in Pancreatic Islet -Cell Biology
Published in:Journal of Biological Chemistry
Publication date:2005-07-06
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Published in:Cancer Immunology Immunotherapy
Publication date:2008-01-10
Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
Published in:Hypertension
Publication date:2009-08-03
Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery
Published in:Molecular Cancer Therapeutics
Publication date:2010-06-01
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
Published in:Cancer Medicine
Publication date:2013-03-21
A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas
Published in:The Oncologist
Publication date:2013-03-01
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
Published in:Investigational New Drugs
Publication date:2014-04-09
Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
Published in:Cancer Chemotherapy and Pharmacology
Publication date:2012-06-29
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated met...
Published in:Investigational New Drugs
Publication date:2013-11-01
Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer
Published in:Anti-Cancer Drugs
Publication date:2013-03-01
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
Published in:Investigational New Drugs
Publication date:2014-07-05
HDAC6 is a microtubule-associated deacetylase
Published in:Nature
Publication date:2002-05-23
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
Published in:Journal of Clinical Investigation
Publication date:2013-08-08
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma
Published in:Journal of Clinical Investigation
Publication date:2013-10-15
The Balance of Cell Surface and Soluble Type III TGF-β Receptor Regulates BMP Signaling in Normal and Cancerous Mammary Epithelial Cells
Published in:Neoplasia
Publication date:2014-06-01
Role of TGF- receptor III localization in polarity and breast cancer progression
Published in:Molecular Biology of the Cell
Publication date:2014-05-28
Ectodomain shedding of T RIII is required for T RIII-mediated suppression of TGF- signaling and breast cancer migration and invasion
Published in:Molecular Biology of the Cell
Publication date:2014-06-25
Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data
Published in:Cancer Informatics
Publication date:2014-07-01
The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer
Published in:Gynecologic Oncology
Publication date:2014-11-01
A Phase Ib Study of Combined VEGFR and mTOR Inhibition With Vatalanib and Everolimus in Patients With Advanced Renal Cell Carcinoma
Published in:Clinical Genitourinary Cancer
Publication date:2014-08-01
Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)
Published in:Clinical Cancer Research
Publication date:2013-10-04
Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling
Published in:Oncogene
Publication date:2013-09-30
Dasatinib (BMS-35482) Interacts Synergistically With Docetaxel, Gemcitabine, Topotecan, and Doxorubicin in Ovarian Cancer Cells With High SRC Pathw...
Published in:International Journal of Gynecological Cancer
Publication date:2014-02-01